Rejected at 4:29 a.m. Mar, 04, 2024 ] by Cameron
Author: tarkleson
Related Note: 1485037302273
Rationale for change

not all underlined

Rejection reason

No need to underline subscript

Text Text
Extra
- Also shown to antagonize H1 and 5-HT1A receptors

- Prior to use of cyproheptadine, attempt supportive measures (hydration, cooling, and BP control) and sedation with benzodiazepine

Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch SSRIs, SNRIs, Cyproheptadine
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo

Bootcamp
Watch associated Bootcamp video - Psychiatric Pharmacology: Psychiatric Emergencies
OME

Additional Resources
Empty field
One by one
Empty field
#PANCE::EOR::PSYCH #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #AK_Step2_v12::#OME::04_Psychiatry::11_Catatonia #AK_Step1_v12::#B&B::15_Neuro::01_Introduction_to_Neurology::04_Neurotransmitters::Extra #AK_Step1_v12::#AMBOSS::CZaqdQ #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::01_Antidepressants::Extra #AK_Step1_v12::#UWorld::COMLEX::25198 #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::40_Psychiatric_emergencies::*Serotonin_Syndrome::Treatment #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::19_SSRIs #AK_Step2_v12::#AMBOSS::t70Xnh #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::01_Serotonin_Syndrome #AK_Step2_v12::!Shelf::FM::no_dupes !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#AMBOSS::jSa_zP #AK_Step1_v12::#OME::Clinical::Psychiatry::Personality_and_Psychosis::Catatonia #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #PANCE::BEHAVIORAL::depression #AK_Step2_v12::!Shelf::Neuro::no_dupes #AK_Step2_v12::#UWorld::COMLEX::104693 #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::16_Psychiatric_Emergencies #AK_Step1_v12::#UWorld::Step::2089 #AK_Step2_v12::#AMBOSS::CZaqdQ !AK_UpdateTags::AnKing_Image::AhmedA #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#Resources_by_rotation::Neuro::amboss #AK_Step1_v12::#B&B::17_Psych::04_Pharm::01_Antidepressants::Extra #AK_Step2_v12::#AMBOSS::jSa_zP #AK_Step2_v12::Original_decks::Dorian::neuro::amboss #AK_Step2_v12::#UWorld::Step::20355 #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step1_v12::#B&B::17_Psych::03_Substance_Use_Disorders::04_Other_Drugs #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Original_Decks::Step_1::Zanki_Pharmacology